Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

After finishing 11-6 and making the playoffs, the Chargers are in full offseason mode. Los Angeles is still a couple of ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five years from now. Berkshire Hathaway is hardly doomed. It's not even expected to ...

The Colts are hiring former Cincinnati Bengals defensive coordinator Lou Anarumo, who signals a shift in philosophy from Gus ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

Shares in Meta fell more than 2% on Tuesday, following reports that the social media company is planning to cut around 5% of its workforce through performance-based terminations. According to a ...

It’s about going home. Former New York Giants quarterback Eli Manning is heading back to the Big Easy for Super Bowl LIX at the Caesars Superdome (happening February 9, 2025) and his return comes with ...

As such, Peyton and Eli Manning will be on the call one last time for the final Manningcast of the season. The wild-card weekend installment marks the 11th Manningcast since Week 1 of the 2024 NFL ...

Eli Blumenthal is a senior editor at CNET with ... "most" Android phones and iPhones older than the iPhone 14 series. Apple users with an iPhone 14 (or later) who are running iOS 18 can also ...

The Chargers activated Apple (hamstring) from IR on Friday. Apple remains officially listed as questionable for Saturday's road AFC wild-card matchup against the Texans, but his activation from IR ...

Los Angeles announced receiver Simi Fehoko and cornerback Eli Apple have been activated to the 53-man roster off of injured reserve. Fehoko is back after dealing with an elbow injury and Apple had a ...

Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of best-selling drugs projected for 2025 after the incretins pushed Bristol Myers ...